sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Decoagulant Market Research Report 2021

Global Decoagulant Market Research Report 2021

Home / Categories / Healthcare
Global Decoagulant Market Research Report 2021
Global Decoagulant Market Research Report...
Report Code
RO1/130/9241

Publish Date
11/Nov/2024

Pages
116
PRICE
$ 2900/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 4350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 5800/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
List of Tables
Table 1. Global Decoagulant Sales (K Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Decoagulant Sales (K Doses) Comparison by Application (2021-2027)
Table 3. Global Decoagulant Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Decoagulant Covered in This Study
Table 5. Global Decoagulant Sales (K Doses) of Key Manufacturers (2016-2021)
Table 6. Global Decoagulant Sales Share by Manufacturers (2016-2021)
Table 7. Global Decoagulant Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Decoagulant Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Decoagulant Average Price (USD/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Decoagulant Manufacturing Sites and Area Served
Table 11. Manufacturers Decoagulant Product Type
Table 12. Global Decoagulant Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Decoagulant by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Decoagulant as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Decoagulant Sales by Region (2016-2021) & (K Doses)
Table 16. Global Decoagulant Sales Market Share by Region (2016-2021)
Table 17. Global Decoagulant Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Decoagulant Sales by Country (2016-2021) & (K Doses)
Table 19. North America Decoagulant Sales Market Share by Country (2016-2021)
Table 20. North America Decoagulant Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Decoagulant Revenue Market Share by Country (2016-2021)
Table 22. Europe Decoagulant Sales by Country (2016-2021) & (K Doses)
Table 23. Europe Decoagulant Sales Market Share by Country (2016-2021)
Table 24. Europe Decoagulant Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Decoagulant Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Decoagulant Sales by Region (2016-2021) & (K Doses)
Table 27. Asia Pacific Decoagulant Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Decoagulant Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Decoagulant Revenue Market Share by Region (2016-2021)
Table 30. Latin America Decoagulant Sales by Country (2016-2021) & (K Doses)
Table 31. Latin America Decoagulant Sales Market Share by Country (2016-2021)
Table 32. Latin America Decoagulant Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Decoagulant Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Decoagulant Sales by Country (2016-2021) & (K Doses)
Table 35. Middle East and Africa Decoagulant Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Decoagulant Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Decoagulant Revenue Market Share by Country (2016-2021)
Table 38. Global Decoagulant Sales (K Doses) by Type (2016-2021)
Table 39. Global Decoagulant Sales Market Share by Type (2016-2021)
Table 40. Global Decoagulant Revenue (Million US$) by Type (2016-2021)
Table 41. Global Decoagulant Revenue Share by Type (2016-2021)
Table 42. Global Decoagulant Price (USD/Dose) by Type (2016-2021)
Table 43. Global Decoagulant Sales (K Doses) by Application (2016-2021)
Table 44. Global Decoagulant Sales Market Share by Application (2016-2021)
Table 45. Global Decoagulant Revenue (Million US$) by Application (2016-2021)
Table 46. Global Decoagulant Revenue Share by Application (2016-2021)
Table 47. Global Decoagulant Price (USD/Dose) by Application (2016-2021)
Table 48. Sanofi Corporation Information
Table 49. Sanofi Description and Business Overview
Table 50. Sanofi Decoagulant Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 51. Sanofi Decoagulant Product
Table 52. Sanofi Recent Developments/Updates
Table 53. Bayer Corporation Information
Table 54. Bayer Description and Business Overview
Table 55. Bayer Decoagulant Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 56. Bayer Decoagulant Product
Table 57. Bayer Recent Developments/Updates
Table 58. Boehringer Ingelheim Corporation Information
Table 59. Boehringer Ingelheim Description and Business Overview
Table 60. Boehringer Ingelheim Decoagulant Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 61. Boehringer Ingelheim Decoagulant Product
Table 62. Boehringer Ingelheim Recent Developments/Updates
Table 63. Johnson & Johnson Corporation Information
Table 64. Johnson & Johnson Description and Business Overview
Table 65. Johnson & Johnson Decoagulant Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 66. Johnson & Johnson Decoagulant Product
Table 67. Johnson & Johnson Recent Developments/Updates
Table 68. Genentech (Roche) Corporation Information
Table 69. Genentech (Roche) Description and Business Overview
Table 70. Genentech (Roche) Decoagulant Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 71. Genentech (Roche) Decoagulant Product
Table 72. Genentech (Roche) Recent Developments/Updates
Table 73. AstraZeneca Corporation Information
Table 74. AstraZeneca Description and Business Overview
Table 75. AstraZeneca Decoagulant Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 76. AstraZeneca Decoagulant Product
Table 77. AstraZeneca Recent Developments/Updates
Table 78. Bristol-Myers Squibb Corporation Information
Table 79. Bristol-Myers Squibb Description and Business Overview
Table 80. Bristol-Myers Squibb Decoagulant Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 81. Bristol-Myers Squibb Decoagulant Product
Table 82. Bristol-Myers Squibb Recent Developments/Updates
Table 83. Aspen Corporation Information
Table 84. Aspen Description and Business Overview
Table 85. Aspen Decoagulant Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 86. Aspen Decoagulant Product
Table 87. Aspen Recent Developments/Updates
Table 88. Lilly Corporation Information
Table 89. Lilly Description and Business Overview
Table 90. Lilly Decoagulant Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 91. Lilly Decoagulant Product
Table 92. Lilly Recent Developments/Updates
Table 93. Otsuka Corporation Information
Table 94. Otsuka Description and Business Overview
Table 95. Otsuka Decoagulant Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 96. Otsuka Decoagulant Product
Table 97. Otsuka Recent Developments/Updates
Table 98. Pfizer Corporation Information
Table 99. Pfizer Description and Business Overview
Table 100. Pfizer Decoagulant Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 101. Pfizer Decoagulant Product
Table 102. Pfizer Recent Developments/Updates
Table 103. Daiichi Sankyo Corporation Information
Table 104. Daiichi Sankyo Description and Business Overview
Table 105. Daiichi Sankyo Decoagulant Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 106. Daiichi Sankyo Decoagulant Product
Table 107. Daiichi Sankyo Recent Developments/Updates
Table 108. The Medicines Company Corporation Information
Table 109. The Medicines Company Description and Business Overview
Table 110. The Medicines Company Decoagulant Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 111. The Medicines Company Decoagulant Product
Table 112. The Medicines Company Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Decoagulant Distributors List
Table 116. Decoagulant Customers List
Table 117. Decoagulant Market Trends
Table 118. Decoagulant Growth Drivers
Table 119. Decoagulant Market Restraints
Table 120. Global Decoagulant Sales Forecast by Type (2022-2027) & (K Doses)
Table 121. Global Decoagulant Sales Market Share Forecast by Type (2022-2027)
Table 122. Global Decoagulant Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 123. Global Decoagulant Revenue Market Share Forecast by Type (2022-2027)
Table 124. Global Decoagulant Sales Forecast by Application (2022-2027) & (K Doses)
Table 125. Global Decoagulant Sales Market Share Forecast by Application (2022-2027)
Table 126. Global Decoagulant Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 127. Global Decoagulant Revenue Market Share Forecast by Application (2022-2027)
Table 128. Global Decoagulant Sales Forecast by Region (2022-2027) & (K Doses)
Table 129. Global Decoagulant Sales Market Share Forecast by Region (2022-2027)
Table 130. Global Decoagulant Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 131. Global Decoagulant Revenue Market Share Forecast by Region (2022-2027)
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Decoagulant
Figure 2. Global Decoagulant Market Share by Type in 2020 & 2027
Figure 3. Platelet aggregation inhibitors (PAI) Product Picture
Figure 4. Low-molecular-weight Heparin (LMWH) Product Picture
Figure 5. Direct thrombin inhibitor (DTI) Product Picture
Figure 6. Direct factor Xa inhibitors (DFXa) Product Picture
Figure 7. Vitamin K antagonists (VKA) Product Picture
Figure 8. Others Product Picture
Figure 9. Global Decoagulant Market Share by Application in 2020 & 2027
Figure 10. VTE
Figure 11. ACS/MI
Figure 12. AF
Figure 13. Others
Figure 14. Global Decoagulant Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Decoagulant Market Size 2016-2027 (US$ Million)
Figure 16. Global Decoagulant Sales 2016-2027 (K Doses)
Figure 17. Global Decoagulant Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 18. Decoagulant Sales Share by Manufacturers in 2020
Figure 19. Global Decoagulant Revenue Share by Manufacturers in 2020
Figure 20. The Global 5 and 10 Largest Decoagulant Players: Market Share by Revenue in 2020
Figure 21. Decoagulant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 22. Global Decoagulant Sales Market Share by Region (2016-2021)
Figure 23. Global Decoagulant Sales Market Share by Region in 2020
Figure 24. Global Decoagulant Revenue Market Share by Region (2016-2021)
Figure 25. Global Decoagulant Revenue Market Share by Region in 2020
Figure 26. U.S. Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Canada Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Germany Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. France Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. U.K. Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Italy Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Russia Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Japan Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. South Korea Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. India Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Australia Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Taiwan Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Indonesia Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Thailand Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Malaysia Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Philippines Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Vietnam Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Mexico Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Brazil Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Argentina Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Turkey Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Saudi Arabia Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. U.A.E Decoagulant Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Sales Market Share of Decoagulant by Type (2016-2021)
Figure 51. Sales Market Share of Decoagulant by Application (2016-2021)
Figure 52. Sales Market Share of Decoagulant by Application in 2020
Figure 53. Revenue Share of Decoagulant by Application (2016-2021)
Figure 54. Revenue Share of Decoagulant by Application in 2020
Figure 55. Manufacturing Cost Structure of Decoagulant
Figure 56. Manufacturing Process Analysis of Decoagulant
Figure 57. Decoagulant Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
LIST OF FIGURE

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com